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Introduction
Chronic diseases are among the most common health 
problems around the world that people’s health habits 
and behaviors dramatically affect their affliction and 
severity.1 Bone and joints disease is one of the most 
common diseases in both the developed and developing 
countries, in a way that in an international action during 
the period 2000-2010 has been entitled as bone and 
joint diseases.2 Rheumatoid arthritis is a progressive 
autoimmune disease with variable clinical symptoms. 
Rheumatoid arthritis starts with periods of inflammation 
in the synovium, which causes thickening and edema in 
it. Synovial inflammation produced in the joint or joints 
results in their inflammation, tenderness, and stiffness, 
which can be associated with fatigue, weight loss, anxiety, 
and depression. This disease can be a significant reason 
for disability and death.3 Rheumatoid arthritis is an 
incapacitating autoimmune disease that affects between 
0.5% and 1% of the adult population throughout the 
world.4 The main complaints of these patients are a pain, 
disability, and fatigue. A significant number of patients 
with rheumatoid arthritis experience severe exhaustion. 
Different research in the psyche domain has shown that 
the chronicity of this disease affects the physical and 
cognitive variables of these patients, including their 
depression.5
On the other hand, C-reactive protein (CRP) is a 
sensitive and non-specific index of inflammation that 
has widely studied.6 This protein binds to a wide variety 
of materials such as microbial polysaccharides and 
phosphatidylcholine, which damage the membrane of the 
cell.7 Also, CRP increases the activity of phagocytosis and 
activates the classical complement pathway.8 Today, CRP 
is used to identify and control a variety of diseases, but 
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Abstract
Background: Rheumatoid arthritis is a progressive autoimmune disease with variable clinical 
symptoms. This study aimed to investigate the effectiveness of cognitive behavioral training on 
C-reactive protein (CRP) and depression in patients with rheumatoid arthritis.
Methods: This research was a semi-experimental study with a pretest-posttest design and a control 
group. The statistical population of this study involved all women suffering from rheumatoid arthritis 
who went to Iran Rheumatology Center. From among them, 60 individuals were randomly selected 
and consigned to the control and experimental groups. The control group received only medication, 
and an educational package about rheumatoid arthritis provided for them. Beck’s depression and 
biochemical evaluations questionnaires were used to measure dependent variables. To analyze the 
data, multivariate analysis of covariance and SPSS. 22 software were used.
Results: The mean (SD) of depression in the experimental group in the pretest was 25.5 (3.8), which 
decreased to 18.9 (4.2) in the post-test (P < 0.01), but the mean (SD) of the control group was not 
statistically significant. Also, the mean (SD) of the CRP in the experimental group was 27.3 (6.9) in 
the pretest, which increased to 22.8 (4.6) in the post-test (P < 0.01), but the mean (SD) of the control 
group was not statistically significant.
Conclusion: This research revealed that cognitive behavioral training led to a reduction of CRP and 
depression in patients with rheumatoid arthritis.
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research on cystatin C, particularly the effects of physical 
activity on concentration changes, is limited.9 
Cognitive-behavioral therapies considered as modern 
growth and development in psychological treatment. 
Nevertheless, during a reasonably short time, it has been 
able to absorb much interest from the clinical experts. 
Cognitive-behavioral therapy is a combination of cognitive 
and behavioral approaches.10 In this kind of treatment, the 
patient is assisted to recognize his/her distorted thinking 
patterns and ineffective behaviors. In order to be able to 
change these distorted and ineffective thoughts, regular 
discussions, and well-organized behavioral assignments 
provided for the patient.11,12 The findings show that there 
is a relationship between perceptual representations of 
disease and mood and behavioral efficacy in chronic 
patients. These findings are significant because they 
indicate that there are conformity and accommodation 
between the predictions of the Leventhal’s self-regulation 
model and the underlying theories of cognitive-behavioral 
interventions that accept the presence of a relationship 
between thoughts, feelings (emotional feelings, physical 
senses) and behavior.13,14 Investigations in patients with 
rheumatoid arthritis show that there is a relationship 
between the emotional-cognitive dimensions and the 
behavior of the disease in patients who have rheumatoid 
arthritis. The results of various studies15,16 indicate the 
influence of cognitive-behavioral interventions on 
patients with rheumatoid arthritis.
Concerning the fact that rheumatic diseases impact 
various aspects of the patients’ daily life and result in 
harms that reduce their ability to perform specific tasks 
and activities.17 Also, on the other hand, in different 
studies, it has been shown that rheumatic diseases are 
often associated with a high outbreak of psychiatric 
disorders and psychological distresses.18 Therefore, 
there is a necessity to do investigations on this group of 
patients and the psychological interventions. The present 
study aimed to determine the effectiveness of cognitive-
behavioral training on the rate of CRP and depression in 
patients who have rheumatoid arthritis.
Methods
The present study was a semi-experimental type with a 
pretest-posttest design and control group. The population 
of this research included 200 women who have rheumatoid 
arthritis that referred to rheumatology specialist in 
Iranian Rheumatism Center in Tehran. One-Hundred 
participants were randomly selected, and then 60 of these 
patients whose depression test scores were higher than 
20 in their Beck depression test, and their CRP in blood 
tests was higher than 12, were randomly assigned into 2 
experimental and control groups (N=30). There were 60 
patients with rheumatoid arthritis who had CRP higher 
than 12, and their depression score was higher than 20 
in the Beck test, who were selected by simple random 
sampling method.
Female patients referred to the Iranian Rheumatism 
Center examined under the supervision of a specialist in 
rheumatology, and their disease diagnosed as rheumatoid 
arthritis, after being introduced to a therapist who was a 
graduate student and selecting a few in the experimental 
group, they went under behavioral treatment. Of course, 
the control group also received a package of applied 
information on rheumatic disease. The overall reason 
for women’s selection was that the incidence of this 
illness in women was three times in comparison with its 
incidence in men. The physician prescribed drug therapy 
for rheumatoid arthritis, including Prednisolone and 
Sulfasalazine. Cognitive behavioral training implemented. 
To the experimental group in the first session, the training 
given along with the training package and its benefits 
explained to them. Then, every week, two or three sessions 
and a total of 3 to 4 weeks of 30-minute training were 
individually held for each patient. All of these conducted 
during eight sessions. The experimental group became 
familiar with positive thinking in the second session and 
the benefits of learning this type of thinking in order to 
prevent psychological problems explained. In the third 
session, positive thinking to stop negative thoughts taught 
and methods to prevent unwanted thoughts provided. 
The fourth session was about teaching anxiety reduction 
with the help of positive thinking, during the fifth 
session the therapist taught how to reduce depression 
with the help of positive thinking, the sixth session was 
about stress management with relaxation exercises and 
time management. The seventh session of training was 
about stress management through the method of being 
decisive. In the eighth session, the therapist taught 
stress management by introducing breathing exercises, 
meditation, and yoga. After three months, the two groups 
took a posttest that was the same Beck’s depression test 
and blood test to determine the amount of CRP. Different 
factors may influence CRP level, but for eliminating these 
effects and bias in results, rheumatoid arthritis patients 
were in the same situation which other probable factors 
controlled. 
Blood Sampling
To assess biochemical variables, blood sampling was 
performed after 12-14 hours of fasting (at 8 am) and in 
two stages, i.e., before treatment, and after cognitive-
behavioral therapy, and in both control and experimental 
groups. In the first phase, because of taking blood samples, 
the subjects were informed to not undergo severe activity 
two days before the test. Then they were in a sitting and 
resting position that 5 milliliters of blood were taken 
from the right hand (8-10 am). In the second phase, after 
completion of cognitive-behavioral therapy, and 72 hours 
after the last treatment session, like the first phase and 
in similar conditions, the subjects tested for any changes 
after behavioral treatment. 
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Biochemical Evaluations
The concentration of CRP was determined using a 
commercially available kit with high-sensitivity ELISA 
method (IBL, Germany) and cysteine   C concentration 
was determined through enzymatic met h od using 
commercial kit (Biowendo, UK).
Beck Depression Test
This questionnaire was developed by Beck in 1988 and 
included 21 items. By examining the research that had 
this tool, Beck and his colleagues found that its validity 
coefficient was varied from 0.48 to 0.86 in terms of 
the interval between running times and the type of 
population tested. In 1996, Beck et al again obtained the 
validity test of 0.93 per week.19 Various studies have also 
conducted the validity of Beck’s depression inventory. 
The mean correlation of Beck’s Inventory with Hamilton 
Psychiatric Scale (HRSD), Zong Self-Measurement Scale, 
Depression Scale (MMPI), Multiple Sclerosis Depression 
Scale, and SCL-90 was more than 0.65. Among these 
studies, Sepehrmanesh et al’s research could mention 
that its reliability coefficient in Iran obtained 0.78.20 The 
internal consistency coefficient of Cronbach’s alpha in 
this research was 0.79.
In order to test the research hypotheses, the mean 
scores of the pretest and posttest of the 2 experimental 
and control groups analyzed by multivariate covariance 
analysis.
Results
The mean (SD) of the participants’ age was 39.8 (10.11). 
Each of the control and experimental groups consisted 
of 10 women with an average age of 25-68 years, and the 
educational level ranged from grades fifth of primary 
school to a master of arts, and 25% were single, and the 
rest were married.
By examining the results of the Box test, it revealed that 
there it is no significant (MBox= 2.716, F = (3, 58320.000) 









Experimental 25.5 (3.8) 18.9 (4.2) 0.001
Control 25.6 (3.2) 25.3 (3.1) 0.54
CRP
Experimental 27.3 (6.9) 22.8 (4.6) 0.0001
Control 26.9 (6.2) 26.4 (5.9)
0.61
Table 2. Results of Covariance Analysis of Dependent Variable Components













244.237 1 244.237 42.953 0.0001 0.729
= 0.796, P > 0.05), so the assumption of the equality of 
the variance-covariance matrices is not rejected. Also, 
according to the results of Levene test (Table 1), lack of 
significant difference between the dependent variables, the 
equality of variances is established, and the performance 
of MANCOVA is possible.
Also, in the table above, the ANCOVA single variate 
covariance analysis has been shown given that there are 
two dependent variables. The Eta value indicates that 
approximately 50% of the variance of the depression 
variable, and approximately 70% of the variance of the 
CRP variable considered for the group variable. The 
results of Table 2 show that there is a significant difference 
between the experimental group that was influenced 
by the cognitive behavioral therapy training and the 
control group that did not receive any training, and this 
difference is for the benefit of the training group. Patients 
undergoing CBT training showed slight depression and 
little CRP than the control group.
Discussion
This study showed that the mean (SD) of depression in the 
experimental group was 25.5 (3.8) in the pretest, which 
decreased to 18.9 (4.2) in the post-test (P <0.01), but the 
mean (SD) of the control group in the pretest was 25.6 
(3.2), which decreased to 25.3 (3.1) in the post-test, which 
was not statistically significant. Also, the mean (SD) of 
the CRP in the experimental group was 27.3 (6.9) during 
the pretest, which increased to 22.8 (4.6) in the post-test 
(P <0.01), but the mean (SD) of the control group was 
26.26 (6.2) in the pretest, which reached to 26.4 (5.9) in 
the post-test, which was not statistically significant. These 
findings were consistent with the results of Hamzehpour 
Haghighi et al21 and Nazemi Ardakani et al.22
Based on the many studies conducted around the world, 
the majority of patients with rheumatoid arthritis suffer 
from depression and anxiety. The reason that these people 
are afflicted with depression is that these patients suffer 
from much pain and thus become depressed because the 
pain caused by the disease prevents them from doing their 
daily routine. Depression exacerbates their illness, and 
they suffer from a defective cycle, and it is also right about 
anxiety, and of course, as described above, anxiety is one of 
the factors to determine this disease. Using psychological 
training such as cognitive behavioral therapy to reduce 
the depression of these individuals can be effective even 
in the improvement of this disease.
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The result of this research showed that cognitive 
behavioral training is effective in reducing depression 
and CRP in patients with rheumatoid arthritis. This 
finding was consistent with the results of Sharp et al.’s 
research on the effect of the cognitive-behavioral therapy 
on reduction of this disease and reduction of CRP. The 
disease causes the patient not to be able to do their daily 
tasks and to be dependent on others in doing their very 
simple act. Deformation of the joints involved, such 
as hand joint, attracting the attention of others to this 
joint deformation, fast exhaustion after doing works that 
in the opinion of others are very simple, taking more 
than 12 pills per day. Also, many other problems cause 
the patient to feel a sense of inadequacy in his/her life, 
and as a result suffer depression, that this per se will 
result in exacerbation of this illness and, unfortunately, 
a defective cycle would be created. In this way, as the 
level of depression increases, the disease gets worse, the 
quality of patient’s life deteriorates, depression becomes 
more severe, and thus, this cycle continues permanently. 
However, through receiving the cognitive behavioral 
training, the patient initially overwhelms his/her negative 
thoughts that exacerbate depression and then substitutes 
positive thoughts instead. Therefore the quality of his life 
increases, the rate of depression comes down, and the 
process of healing accelerates. In explaining this finding, 
it could say that cognitive behavioral training by reducing 
CRP helps patients with rheumatoid arthritis to improve 
their disease because when CRP in the blood test of a 
patient is over 12, it is an evidence of inflammation in 
the body. This symptom can be one of the reasons for 
rheumatic disease. The presence of this inflammation in 
the blood may result in inflammation of the joints, and 
due to this inflammation, the joints will be painful and 
sensitive, in such a way that the patient is in trouble even 
in doing their smallest actions. Bearing a lot of pain even 
at the time of resting, breakdown of joints and reduction 
in the daily functioning reduces these patients’ life quality 
that through cognitive behavioral training they can be 
helped to reduce these pains and thus improving the 
quality of their life can be effective in improving and 
reducing the symptoms of this disease.
The degree of collaboration between patients with 
rheumatoid arthritis is very low because they are not 
familiar with the positive effects of cognitive therapies. 
There was no suitable place for training and, of course, 
processing after the end of the training. Time and space 
constraints prevent the processing of treatment results 
after the end of the study. There are a few health centers 
for patients with rheumatoid arthritis in the country that 
provide all of their required services, and none of them 
offers psychological services, even though the presence 
of psychological disorders has proven in these patients. 
It would be better to increase the number of these centers 
and, of course, to provide psychological services. It 
suggested that the specialist physicians ask patients with 
rheumatoid arthritis to go to the psychological centers to 
receive the required services. It is advisable to continue 
processing up to 6 months or more so that the result of 
treatment is better. Further research should do on the 
anxiety of patients with rheumatoid arthritis, and more 
patients should participate in order to generalize the 
findings of this research. It seems that many patients with 
rheumatoid arthritis need to change their attitudes to 
accelerate and increase the function of drug therapy, for 
example, persuading the participants to accept culturally 
that psychological treatments also help to accelerate drug 
therapies. 
Conclusion
This research showed that cognitive-behavioral training 
resulted in CRP and depression decline in patients with 
rheumatoid arthritis.
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